Literature DB >> 10664909

Identification, characterization and purification of the lantibiotic staphylococcin T, a natural gallidermin variant.

B Furmanek1, T Kaczorowski, R Bugalski, K Bielawski, J Bohdanowicz, A J Podhajska, J Bogdanowicz.   

Abstract

Staphylococcin T (StT), an antibacterial agent produced by a Staphylococcus cohnii T strain, was purified to homogeneity by ammonium sulphate precipitation, gel filtration, cation exchange and fast performance liquid chromatography (FPLC). The final yield was about 20%, and over a 1000-fold increase in the specific activity was obtained. Mass determination (2166 Da), amino acid sequencing (Ile-Ala-Xaa-Lys-Phe-Leu-Xaa-Xaa-Pro-Gly-Xaa-Ala-Lys-block) and DNA sequencing demonstrated that StT is identical to gallidermin, a lanthionine-containing antimicrobial peptide. StT has a broad spectrum of bactericidal activity against Gram-positive and some Gram-negative bacteria. StT appears to damage cell membrane, and as a result causes an efflux of ions and an immediate block in macromolecular synthesis. Moreover, electron microscopic observations reveal morphological changes, with a loss of ribosomes and condensation of the nucleoid DNA. These changes are followed by a dissolution of the cell contents resulting in a bacterial ghost composed of seemingly intact cell walls with remnants of the cytoplasmic membrane and internal structure. Since StT exhibits antimicrobial activity especially against the Staphylococcus species, this compound may be of use in the treatment of staphylococcal infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10664909     DOI: 10.1046/j.1365-2672.1999.00937.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  8 in total

1.  Requirements of the engineered leader peptide of nisin for inducing modification, export, and cleavage.

Authors:  Annechien Plat; Leon D Kluskens; Anneke Kuipers; Rick Rink; Gert N Moll
Journal:  Appl Environ Microbiol       Date:  2010-11-19       Impact factor: 4.792

2.  Effect of lantibiotic gallidermin against biogenic amine-producing faecal staphylococci from ostriches and pheasants.

Authors:  Andrea Lauková; Anna Kandričáková; Pavel Pleva; Leona Buňková; Jana Ščerbová
Journal:  Folia Microbiol (Praha)       Date:  2017-01-13       Impact factor: 2.099

Review 3.  Intracellular Targeting Mechanisms by Antimicrobial Peptides.

Authors:  Cheng-Foh Le; Chee-Mun Fang; Shamala Devi Sekaran
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  Characterisation of Faecal Staphylococci from Roe Deer (Capreolus capreolus) and Red Deer (Cervus elaphus) and Their Susceptibility to Gallidermin.

Authors:  A Lauková; E Bino; I Kubašová; V Strompfová; R Miltko; G Belzecki; M Pogány Simonová
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

5.  The use of fosmid metagenomic libraries in preliminary screening for various biological activities.

Authors:  Agnieszka Felczykowska; Aleksandra Dydecka; Małgorzata Bohdanowicz; Tomasz Gąsior; Marek Soboň; Justyna Kobos; Sylwia Bloch; Bożena Nejman-Faleńczyk; Grzegorz Węgrzyn
Journal:  Microb Cell Fact       Date:  2014-07-22       Impact factor: 5.328

Review 6.  Recipe for Success: Suggestions and Recommendations for the Isolation and Characterisation of Bacteriocins.

Authors:  Ellen Twomey; Colin Hill; Des Field; Máire Begley
Journal:  Int J Microbiol       Date:  2021-06-17

7.  Enhanced production, purification, characterization and mechanism of action of salivaricin 9 lantibiotic produced by Streptococcus salivarius NU10.

Authors:  Abdelahhad Barbour; Koshy Philip; Sekaran Muniandy
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

8.  Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91.

Authors:  Benedykt Wladyka; Katarzyna Wielebska; Marcin Wloka; Oliwia Bochenska; Grzegorz Dubin; Adam Dubin; Pawel Mak
Journal:  Appl Microbiol Biotechnol       Date:  2012-11-30       Impact factor: 4.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.